Apogee Therapeutics reported total assets of $1335.81M and total liabilities of $141.21M for the quarter ended Jun 2026, up 103.1% year over year. This balance sheet covers 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current Assets | |||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 4.97M | 151.89M | 125.10M | 188.27M | 118.32M | 485.46M | 307.30M | 118.78M | 141.79M | 106.92M | 124.19M | 107.91M | 131.55M | 451.80M | 105.57M | ||
| Short-term InvestmentsInvestments (Current) | 234.60M | 277.14M | 330.74M | 368.93M | 407.30M | 378.86M | 406.41M | 381.23M | 419.40M | 598.64M | 608.10M | 866.40M | |||||
| Cash & Current Investments | 4.97M | 151.89M | 125.10M | 422.87M | 395.46M | 816.20M | 676.23M | 526.08M | 520.65M | 513.33M | 505.42M | 527.31M | 730.19M | 1,059.90M | 971.97M | ||
| Prepaid Assets | 0.17M | 5.60M | 3.57M | 2.95M | 4.41M | 5.62M | 8.43M | 9.06M | 8.20M | 10.70M | 12.81M | 11.17M | 13.91M | 19.81M | |||
| Current Assets | 152.06M | 130.67M | 426.42M | 398.41M | 820.61M | 681.85M | 534.48M | 529.71M | 521.53M | 516.12M | 540.10M | 741.36M | 1,073.80M | 991.73M | |||
| Non-Current Assets | |||||||||||||||||
| Property, Plant & Equipment (Net) | 0.38M | 0.70M | 0.71M | 1.42M | 1.96M | 5.70M | 6.44M | 6.03M | 5.69M | 5.28M | 4.82M | ||||||
| Long-Term Investments | 113.40M | 227.75M | 210.42M | 168.11M | 115.80M | 61.64M | 172.73M | 198.40M | 321.94M | ||||||||
| Long-Term Deferred Tax | 30.75M | ||||||||||||||||
| Other Non-Current Assets | 3.50M | 0.40M | 0.40M | 0.47M | 0.51M | 0.50M | 7.34M | 8.86M | 8.74M | 8.67M | 8.52M | 10.61M | |||||
| Non-Current Assets | 3.00M | 3.05M | 118.80M | 241.80M | 224.24M | 192.63M | 141.65M | 86.06M | 195.78M | 219.86M | 344.08M | ||||||
| Assets | 152.06M | 130.67M | 426.42M | 401.40M | 823.66M | 800.66M | 776.29M | 753.95M | 714.16M | 657.77M | 626.16M | 937.13M | 1,293.65M | 1,335.81M | |||
| Liabilities | |||||||||||||||||
| Current Liabilities | |||||||||||||||||
| Accounts Payables | 0.42M | 11.15M | 1.21M | 2.14M | 4.30M | 5.53M | 2.22M | 1.07M | 2.44M | 5.68M | 0.38M | 1.22M | 1.24M | 3.08M | |||
| Payables | 0.42M | 11.15M | 1.21M | 2.14M | 4.30M | 5.53M | 2.22M | 1.07M | 2.44M | 5.68M | 0.38M | 1.22M | 1.24M | 3.08M | |||
| Accumulated Expenses | 9.56M | 6.47M | 15.97M | 17.31M | 16.11M | 17.41M | 27.53M | 24.25M | 26.54M | 21.85M | 29.59M | 23.18M | 28.58M | 32.06M | |||
| Other Accumulated Expenses | 0.20M | 1.83M | 0.69M | 1.24M | 2.14M | 1.01M | 1.69M | ||||||||||
| Current Leases | 1.10M | 1.14M | 1.70M | 2.90M | 3.23M | 4.00M | 4.03M | 4.10M | 3.50M | 3.14M | 2.40M | ||||||
| Total Current Liabilities | 9.98M | 17.61M | 17.18M | 20.56M | 21.55M | 24.62M | 32.61M | 28.56M | 32.96M | 31.55M | 34.05M | 27.91M | 32.95M | 37.51M | |||
| Non-Current Liabilities | |||||||||||||||||
| Preferred Stock Liabilities | 3.77M | 8.17M | 177.47M | 148.50M | 177.47M | 148.50M | |||||||||||
| Operating Leases | 0.93M | 0.63M | 4.10M | 9.30M | 8.60M | 7.84M | 6.82M | 5.80M | 5.34M | 4.91M | 4.50M | ||||||
| Non-Current Deferred Tax Liability | 0.57M | ||||||||||||||||
| Other Non-Current Liabilities | 8.00M | 5.90M | 6.60M | 5.20M | 2.50M | 1.20M | 0.50M | 0.10M | 0.10M | 2.10M | 0.60M | 0.20M | |||||
| Total Non-Current Liabilities | 1.98M | 11.71M | 10.58M | 16.29M | 19.68M | 25.82M | 41.38M | 37.06M | 38.27M | 39.82M | 31.15M | 37.26M | 141.01M | ||||
| Total Liabilities | 4.43M | 24.09M | 9.98M | 46.64M | 17.61M | 17.18M | 21.49M | 22.18M | 27.02M | 41.88M | 37.16M | 40.80M | 38.37M | 39.82M | 33.25M | 37.86M | 141.21M |
| Shareholder's Equity | |||||||||||||||||
| Common Equity | -4.43M | -24.09M | -35.39M | -46.64M | -64.42M | 409.24M | 379.91M | 801.48M | 773.64M | 734.40M | 716.79M | 673.36M | 619.40M | 586.34M | 903.88M | 1,255.79M | 1,194.60M |
| Liabilities and Shareholders Equity | 152.06M | 130.67M | 426.42M | 401.40M | 823.66M | 800.66M | 776.29M | 753.95M | 714.16M | 657.77M | 626.16M | 937.13M | 1,293.65M | 1,335.81M | |||
| Retained Earnings | -39.78M | -71.20M | 501.14M | 503.35M | 957.52M | 963.61M | 969.83M | 1,021.79M | 1,033.54M | 1,046.07M | 1,077.68M | 1,464.56M | 1,892.41M | 1,918.83M | |||
| Treasury Shares | 65.09M | 65.09M | 65.09M | 45.09M |